Giuseppe Polimeno

776 total citations
17 papers, 474 citations indexed

About

Giuseppe Polimeno is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Giuseppe Polimeno has authored 17 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 6 papers in Neurology. Recurrent topics in Giuseppe Polimeno's work include Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Giuseppe Polimeno is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Giuseppe Polimeno collaborates with scholars based in Italy. Giuseppe Polimeno's co-authors include Stefano Luminari, Francesco Merli, Massimo Federico, Luigi Marcheselli, Paolo G. Gobbi, Nicola Di Renzo, F. Angrilli, Luca Baldini, Caterina Stelitano and Patrizio Mazza and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Giuseppe Polimeno

16 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Polimeno Italy 10 305 227 130 113 83 17 474
M. Bast United States 8 558 1.8× 347 1.5× 135 1.0× 78 0.7× 38 0.5× 10 609
Giulia Cervetti Italy 14 341 1.1× 252 1.1× 103 0.8× 105 0.9× 131 1.6× 37 615
Marcel Hayat France 12 264 0.9× 160 0.7× 82 0.6× 135 1.2× 168 2.0× 20 579
Vittorio Silingardi Italy 12 202 0.7× 342 1.5× 44 0.3× 99 0.9× 80 1.0× 28 619
Simone Snijder Netherlands 13 396 1.3× 236 1.0× 178 1.4× 76 0.7× 56 0.7× 25 625
Violaine Safar France 10 281 0.9× 184 0.8× 97 0.7× 94 0.8× 96 1.2× 24 529
E. Dühmke Germany 3 460 1.5× 259 1.1× 177 1.4× 190 1.7× 32 0.4× 7 553
Tariq Muzzafar United States 14 220 0.7× 152 0.7× 48 0.4× 71 0.6× 149 1.8× 34 507
Jakob Werner Hansen Denmark 13 414 1.4× 264 1.2× 70 0.5× 88 0.8× 218 2.6× 39 822
Parth Desai United States 12 295 1.0× 289 1.3× 115 0.9× 53 0.5× 73 0.9× 52 576

Countries citing papers authored by Giuseppe Polimeno

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Polimeno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Polimeno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Polimeno more than expected).

Fields of papers citing papers by Giuseppe Polimeno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Polimeno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Polimeno. The network helps show where Giuseppe Polimeno may publish in the future.

Co-authorship network of co-authors of Giuseppe Polimeno

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Polimeno. A scholar is included among the top collaborators of Giuseppe Polimeno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Polimeno. Giuseppe Polimeno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mazza, Patrizio, Carla Minoia, Angela Melpignano, et al.. (2015). The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP). Annals of Hematology. 95(2). 239–244. 36 indexed citations
2.
Merli, Francesco, Stefano Luminari, Paolo G. Gobbi, et al.. (2015). Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Journal of Clinical Oncology. 34(11). 1175–1181. 68 indexed citations
3.
4.
Gobbi, Paolo G., Francesco Merli, Chiara Coriani, et al.. (2012). Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy. Hematological Oncology. 30(4). 194–199. 15 indexed citations
5.
Sacchi, Stefano, Raffaella Marcheselli, Antonio Lazzaro, et al.. (2011). A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant. Leukemia & lymphoma. 52(10). 1942–1948. 23 indexed citations
6.
Mannina, Donato, Stefano Luminari, Alessandra Dondi, et al.. (2009). Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi. Leukemia & lymphoma. 51(3). 422–429. 2 indexed citations
7.
8.
Federico, Massimo, Stefano Luminari, Emilio Iannitto, et al.. (2009). ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. Journal of Clinical Oncology. 27(5). 805–811. 181 indexed citations
9.
Merli, Francesco, M Bertini, Stefano Luminari, et al.. (2007). Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 48(2). 367–373. 18 indexed citations
10.
Gobbi, P., Chiara Broglia, Francesco Valentino, et al.. (2006). The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL). Annals of Oncology. 17(4). 676–682. 3 indexed citations
11.
Federico, Massimo, Stefano Luminari, Paolo G. Gobbi, et al.. (2006). The length of treatment of aggressive non‐Hodgkin's lymphomas established according to the international prognostic index score: long‐term results of the GISL LA03 study. European Journal Of Haematology. 76(3). 217–229. 7 indexed citations
12.
Morabito, Fortunato, Caterina Stelitano, Stefano Luminari, et al.. (2005). The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL). Bone Marrow Transplantation. 37(3). 283–288. 20 indexed citations
13.
Pozzi, Samantha, Raffaella Marcheselli, Stefano Sacchi, et al.. (2005). Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.. Blood. 106(11). 5057–5057. 24 indexed citations
14.
Ribatti, Doménico, Giuseppe Polimeno, Angelo Vacca, et al.. (2002). Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia. 16(9). 1680–1684. 56 indexed citations
15.
Lorusso, Vito, Gianna Palmieri, Antonella Bianco, et al.. (2000). CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.. International Journal of Oncology. 16(1). 149–54. 6 indexed citations
16.
Munno, I, N.M. Pellegrino, G Barbieri, et al.. (1987). Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients.. PubMed. 52(210-211). 167–73. 3 indexed citations
17.
Covelli, Vito, et al.. (1985). Erythrocyte Deformability Changes in Headache Patients Under Flunarizine Treatment. Cephalalgia. 5(2_suppl). 159–161. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Bast Breakdown of academic impact, for papers by Giulia Cervetti Breakdown of academic impact, for papers by Marcel Hayat Breakdown of academic impact, for papers by Vittorio Silingardi Breakdown of academic impact, for papers by Simone Snijder Breakdown of academic impact, for papers by Violaine Safar Breakdown of academic impact, for papers by E. Dühmke Breakdown of academic impact, for papers by Tariq Muzzafar Breakdown of academic impact, for papers by Jakob Werner Hansen Breakdown of academic impact, for papers by Parth Desai
Rankless by CCL
2026